{"id":176461,"date":"2026-05-06T07:32:00","date_gmt":"2026-05-06T05:32:00","guid":{"rendered":"https:\/\/renewable-carbon.eu\/news\/?p=176461"},"modified":"2026-04-29T13:06:14","modified_gmt":"2026-04-29T11:06:14","slug":"covation-biomaterials-first-commercial-plant-for-biothf-and-bioptmeg-reaches-mechanical-completion-xatryx-brand-unveiled-for-new-non-food-bioptmeg","status":"publish","type":"post","link":"https:\/\/renewable-carbon.eu\/news\/covation-biomaterials-first-commercial-plant-for-biothf-and-bioptmeg-reaches-mechanical-completion-xatryx-brand-unveiled-for-new-non-food-bioptmeg\/","title":{"rendered":"Covation Biomaterials’ First Commercial Plant for bioTHF and bioPTMEG Reaches Mechanical Completion; Xatryx\u00ae, Brand Unveiled for New Non-Food bioPTMEG"},"content":{"rendered":"\n\n
\n
\"\"
\u00a9 CovationBio<\/figcaption><\/figure><\/div>\n\n\n

Covation Biomaterials LLC (“CovationBio\u00ae<\/sup>“), a biomaterials company with advanced technology in the bio-based materials industry, announced\u00a0today\u00a0that its first commercial plant for\u00a0the C4 product platform, including\u00a0bioTHF and bio-based polytetramethylene ether glycol (“PTMEG”), achieved mechanical completion in April 2026. In addition, CovationBio now officially launches the Xatryx\u00ae\u00a0<\/sup>brand for the portfolio of new, non-food, bioPTMEG products to be produced at the plant.<\/strong><\/p>\n\n\n\n

This milestone marks a significant step forward in defossilization of material production, reinforcing the company’s commitment to delivering high-performance, renewable-based solutions to the global market.<\/p>\n\n\n\n

The C4 facility is located in Qidong, Jiangsu Province, China. It utilizes an innovative, new-to-the-world process technology developed by CovationBio. With a total investment of RMB 10 billion, the plant is planned in three phases, targeting a future total capacity of 500,000 tons per year of bio-based materials. The first phase, which is now mechanically complete, has a 50,000-ton-per-year commercial production capacity for both bioTHF and bioPTMEG. Commercial production is expected to begin in the second half of 2026.<\/p>\n\n\n\n

\n

Feifeng You, President of CovationBio, <\/strong>commented:\u00a0“The Xatryx\u00ae<\/sup>\u00a0name conveys our spirit of relentless exploration to develop processes and products that deliver high performance and support defossilization of the materials industry. As an important building block, Xatryx\u00ae<\/sup>\u00a0products provide many possibilities to improve one’s quality of life while taking good care of our planet. To achieve this, we leverage an abundant, non-food, agricultural by-product that is directly converted to a chemical feedstock, which our Advanced ThermoChemical technology uses to create Xatryx\u00ae<\/sup>\u00a0products.”<\/p>\n<\/blockquote>\n\n\n\n

A Sustainable Alternative to Fossil-Based PTMEG and not Competing with Food Sources<\/strong> <\/h3>\n\n\n\n

As a second-generation bio-based material, Xatryx\u00ae<\/sup> bioPTMEG serves as a drop-in replacement to fossil-based PTMEG, helping customers reduce their reliance on non-renewable materials while maintaining the high-performance of our downstream material applications such as spandex, polyurethanes, and thermoplastic elastomers.<\/p>\n\n\n\n

Key sustainability benefits of Xatryx\u00ae<\/sup> bioPTMEG include:<\/p>\n\n\n\n